Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

1.

Active and passive immunization protects against lethal, extreme drug resistant-Acinetobacter baumannii infection.

Luo G, Lin L, Ibrahim AS, Baquir B, Pantapalangkoor P, Bonomo RA, Doi Y, Adams MD, Russo TA, Spellberg B.

PLoS One. 2012;7(1):e29446. doi: 10.1371/journal.pone.0029446. Epub 2012 Jan 10.

PMID:
22253723
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Active and passive immunization against Acinetobacter baumannii using an inactivated whole cell vaccine.

McConnell MJ, Pachón J.

Vaccine. 2010 Dec 10;29(1):1-5. doi: 10.1016/j.vaccine.2010.10.052. Epub 2010 Nov 18.

PMID:
21044668
[PubMed - indexed for MEDLINE]
3.

Vaccination with outer membrane complexes elicits rapid protective immunity to multidrug-resistant Acinetobacter baumannii.

McConnell MJ, Domínguez-Herrera J, Smani Y, López-Rojas R, Docobo-Pérez F, Pachón J.

Infect Immun. 2011 Jan;79(1):518-26. doi: 10.1128/IAI.00741-10. Epub 2010 Oct 25.

PMID:
20974823
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Acinetobacter baumannii rOmpA vaccine dose alters immune polarization and immunodominant epitopes.

Lin L, Tan B, Pantapalangkoor P, Ho T, Hujer AM, Taracila MA, Bonomo RA, Spellberg B.

Vaccine. 2013 Jan 2;31(2):313-8. doi: 10.1016/j.vaccine.2012.11.008. Epub 2012 Nov 12.

PMID:
23153442
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Outer membrane vesicles as an acellular vaccine against Acinetobacter baumannii.

McConnell MJ, Rumbo C, Bou G, Pachón J.

Vaccine. 2011 Aug 5;29(34):5705-10. doi: 10.1016/j.vaccine.2011.06.001. Epub 2011 Jun 14.

PMID:
21679737
[PubMed - indexed for MEDLINE]
6.

Evaluation of the trimeric autotransporter Ata as a vaccine candidate against Acinetobacter baumannii infections.

Bentancor LV, Routray A, Bozkurt-Guzel C, Camacho-Peiro A, Pier GB, Maira-Litrán T.

Infect Immun. 2012 Oct;80(10):3381-8. doi: 10.1128/IAI.06096-11. Epub 2012 Jul 23.

PMID:
22825448
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections.

Bentancor LV, O'Malley JM, Bozkurt-Guzel C, Pier GB, Maira-Litrán T.

Infect Immun. 2012 Feb;80(2):651-6. doi: 10.1128/IAI.05653-11. Epub 2011 Nov 21.

PMID:
22104104
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Inhibition of LpxC protects mice from resistant Acinetobacter baumannii by modulating inflammation and enhancing phagocytosis.

Lin L, Tan B, Pantapalangkoor P, Ho T, Baquir B, Tomaras A, Montgomery JI, Reilly U, Barbacci EG, Hujer K, Bonomo RA, Fernandez L, Hancock RE, Adams MD, French SW, Buslon VS, Spellberg B.

MBio. 2012 Oct 2;3(5). pii: e00312-12. doi: 10.1128/mBio.00312-12. Print 2012.

PMID:
23033474
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

First steps towards a vaccine against Acinetobacter baumannii.

Garcia-Quintanilla M, Pulido MR, McConnell MJ.

Curr Pharm Biotechnol. 2014 Nov;14(10):897-902. Review.

PMID:
24372252
[PubMed - indexed for MEDLINE]
10.

A mouse model of Acinetobacter baumannii-associated pneumonia using a clinically isolated hypervirulent strain.

Harris G, Kuo Lee R, Lam CK, Kanzaki G, Patel GB, Xu HH, Chen W.

Antimicrob Agents Chemother. 2013 Aug;57(8):3601-13. doi: 10.1128/AAC.00944-13. Epub 2013 May 20.

PMID:
23689726
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Diabetic murine models for Acinetobacter baumannii infection.

Luo G, Spellberg B, Gebremariam T, Bolaris M, Lee H, Fu Y, French SW, Ibrahim AS.

J Antimicrob Chemother. 2012 Jun;67(6):1439-45. doi: 10.1093/jac/dks050. Epub 2012 Mar 2.

PMID:
22389456
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap).

Fattahian Y, Rasooli I, Mousavi Gargari SL, Rahbar MR, Darvish Alipour Astaneh S, Amani J.

Microb Pathog. 2011 Dec;51(6):402-6. doi: 10.1016/j.micpath.2011.09.004. Epub 2011 Sep 22.

PMID:
21946278
[PubMed - indexed for MEDLINE]
13.

Identification of novel vaccine candidates against multidrug-resistant Acinetobacter baumannii.

Moriel DG, Beatson SA, Wurpel DJ, Lipman J, Nimmo GR, Paterson DL, Schembri MA.

PLoS One. 2013 Oct 8;8(10):e77631. doi: 10.1371/journal.pone.0077631. eCollection 2013.

PMID:
24116234
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Innate immune responses to systemic Acinetobacter baumannii infection in mice: neutrophils, but not interleukin-17, mediate host resistance.

Breslow JM, Meissler JJ Jr, Hartzell RR, Spence PB, Truant A, Gaughan J, Eisenstein TK.

Infect Immun. 2011 Aug;79(8):3317-27. doi: 10.1128/IAI.00069-11. Epub 2011 May 16.

PMID:
21576323
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Serum resistance of Acinetobacter baumannii through the binding of factor H to outer membrane proteins.

Kim SW, Choi CH, Moon DC, Jin JS, Lee JH, Shin JH, Kim JM, Lee YC, Seol SY, Cho DT, Lee JC.

FEMS Microbiol Lett. 2009 Dec;301(2):224-31. doi: 10.1111/j.1574-6968.2009.01820.x. Epub 2009 Oct 13.

PMID:
19878322
[PubMed - indexed for MEDLINE]
16.

The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization.

Russo TA, Beanan JM, Olson R, MacDonald U, Cox AD, St Michael F, Vinogradov EV, Spellberg B, Luke-Marshall NR, Campagnari AA.

Infect Immun. 2013 Mar;81(3):915-22. doi: 10.1128/IAI.01184-12. Epub 2013 Jan 7.

PMID:
23297385
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Neutrophils play an important role in host resistance to respiratory infection with Acinetobacter baumannii in mice.

van Faassen H, KuoLee R, Harris G, Zhao X, Conlan JW, Chen W.

Infect Immun. 2007 Dec;75(12):5597-608. Epub 2007 Oct 1.

PMID:
17908807
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Identification of an Acinetobacter baumannii zinc acquisition system that facilitates resistance to calprotectin-mediated zinc sequestration.

Hood MI, Mortensen BL, Moore JL, Zhang Y, Kehl-Fie TE, Sugitani N, Chazin WJ, Caprioli RM, Skaar EP.

PLoS Pathog. 2012;8(12):e1003068. doi: 10.1371/journal.ppat.1003068. Epub 2012 Dec 6. Erratum in: PLoS Pathog. 2013;9(1). 10.1371/annotation/2968451e-04b8-4705-bee9-9e40bceffe67.

PMID:
23236280
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cationic amphiphilic alpha-helical peptides for the treatment of carbapenem-resistant Acinetobacter baumannii infection.

Huang Y, Wiradharma N, Xu K, Ji Z, Bi S, Li L, Yang YY, Fan W.

Biomaterials. 2012 Dec;33(34):8841-7. doi: 10.1016/j.biomaterials.2012.08.026. Epub 2012 Aug 25.

PMID:
22925814
[PubMed - indexed for MEDLINE]
20.

Demonstration of an outer membrane protein that is antigenically specific for Acinetobacter baumannii.

Islam AH, Singh KK, Ismail A.

Diagn Microbiol Infect Dis. 2011 Jan;69(1):38-44. doi: 10.1016/j.diagmicrobio.2010.09.008.

PMID:
21146712
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk